List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 41 studies with search of: "Treatment Interruption" [CONDITION] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)
Condition: HIV Infections
Interventions: Procedure: Structured Treatment Interruption;   Drug: Zidovudine (ZDV);   Drug: Lamivudine (3TC);   Drug: Efavirenz (EFV);   Drug: Ritonavir (NRV);   Drug: Indinavir (IDV)
2 Unknown † Controlling Acute or Early HIV Infection With Antiretroviral Drugs, With or Without a Candidate Vaccine
Condition: HIV Infections
Interventions: Biological: HIV-1 immunogen;   Biological: HIV-1 Immunogen
3 Completed The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
Conditions: HIV Seropositivity;   HIV Infection
Intervention: Drug: (Ampligen) polyI-polyC12U
4 Completed Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Condition: HIV-Associated Lipodystrophy Syndrome
Interventions: Drug: Standard continuous antiretroviral therapy;   Drug: CD-4 guided therapy interruption;   Drug: Viral load driven treatment interruption
5 Withdrawn Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV
Condition: HIV Infections
Interventions: Biological: HIV-1 Immunogen;   Procedure: Structured Treatment Interruption
6 Completed Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
Condition: HIV Infections
Intervention: Biological: ALVAC(2)120(B,MN)GNP (vCP1452)
7 Completed Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
Condition: HIV Infections
Intervention: Biological: Dendritic Cells Pulsed with HIV antigens
8 Completed Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Pegasys (ART Replacement Therapy)
9 Completed Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load
Condition: HIV Infections
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Drug: Aldesleukin
10 Unknown † Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV
Condition: HIV Infections
Intervention:
11 Completed Immune and Viral Outcomes of HIV-1 Therapy Interruption
Condition: HIV Infections
Intervention: Behavioral: Treatment interruption/reinitiation schedule
12 Active, not recruiting Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Didanosine;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Lopinavir/Ritonavir;   Drug: Nevirapine;   Drug: Zidovudine
13 Completed Intermittent Versus Continuous Medication in the Treatment of HIV
Condition: HIV Infection
Intervention: Drug: HAART
14 Completed
Has Results 		Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx
Condition: HIV Infections
Interventions: Drug: Interleukin 2;   Drug: HAART;   Drug: Treatment interruption
15 Completed Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy
Condition: HIV Infection
Intervention:
16 Completed Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients
Condition: HIV Infections
Interventions: Biological: MRK Ad5 HIV-1 gag vaccine;   Other: Vaccine placebo
17 Completed
Has Results 		FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: tenofovir;   Drug: emtricitabine
18 Completed Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection
Condition: HIV Infections
Interventions: Biological: MRKAd5 HIV-1 gag/pol/nef;   Biological: MRKAd5 HIV-1 gag/pol/nef placebo
19 Completed Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs
Condition: HIV Infections
Intervention: Biological: Therapeutic vaccinations from A5058s
20 Completed Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
Condition: HIV Infections
Intervention: Biological: VRC-HIVDNA009-00-VP

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services